Validation of analytic methods for biomarkers used in drug development

Cindy H. Chau, Olivier Rixe, Howard McLeod*, William D. Figg

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

181 Scopus citations


The role of biomarkers in drug discovery and development has gained precedence over the years. As biomarkers become integrated into drug development and clinical trials, quality assurance and, in particular, assay validation become essential with the need to establish standardized guidelines for analytic methods used in biomarker measurements. New biomarkers can revolutionize both the development and use of therapeutics but are contingent on the establishment of a concrete validation process that addresses technology integration and method validation as well as regulatory pathways for efficient biomarker development. This perspective focuses on the general principles of the biomarker validation process with an emphasis on assay validation and the collaborative efforts undertaken by various sectors to promote the standardization of this procedure for efficient biomarker development.

Original languageEnglish
Pages (from-to)5967-5976
Number of pages10
JournalClinical Cancer Research
Issue number19
StatePublished - 1 Oct 2008
Externally publishedYes


Dive into the research topics of 'Validation of analytic methods for biomarkers used in drug development'. Together they form a unique fingerprint.

Cite this